CVE-2025-71423Edgelesssys Contrast before 1.12.2 Workload Secrets Information Disclosure
Updated under an hour ago ()
Does this affect you?
It affects edgelesssys contrast. Add what you run to find out whether that includes you.
EPSS puts the chance of exploitation in the next 30 days at 0.21%, higher than 10% of scored CVEs.
Do this next
Free account, 1 product
Edgelesssys Contrast is a confidential-computing runtime for Kubernetes. In versions 1.9.0 before 1.12.2, the initializer logs the full NewMeshCert response — which contains the workload secret — to standard output at INFO level. As a result, workload secrets are exposed to any Kubernetes user with get or list permission on pods/logs. Because workload secrets are used for encrypted storage and Vault integration, those must also be considered compromised. This is a regression of GHSA-h5f8-crrq-4pw8.
- CVSS
- 7.3 HIGH (v3.1, CNA)CVSS:3.1/AV:A/AC:L/PR:L/UI:N/S:U/C:H/I:H/A:N
- Weakness (CWE)
- CWE-532
- Known exploited
- Not in CISA's KEV catalog
- EPSS (exploitation in the next 30 days)
- 0.21% (percentile 10)
- Assigned by
- VulnCheck
- NVD analysis
- Deferred
- Record last updated
- Oct 8, 2026
- First seen by InfoSec Signals
- Oct 9, 2026
Affected products
edgelesssys contrast edgelesssys:contrast (from the name) | from 1.9.0 before 1.12.2; 1.12.2 not affected | CNA record |
References
- https://github.com/edgelesssys/contrast/security/advisories/GHSA-vxg3-w9rv-rhr2vendor-advisory
- https://github.com/edgelesssys/contrast/commit/5a5512c4af63c17bb66331e7bd2768a863b2f225patch
- https://github.com/edgelesssys/contrast/commit/cf58026b30c43fe7df91eac5322da02e1725d554patch
- https://www.vulncheck.com/advisories/edgelesssys-contrast-before-1.12.2-workload-secrets-information-disclosurethird-party-advisory
The CVE record on cve.org NVD's entry
The CVE record is authoritative. Products marked “from the name” were identified from the CNA's free-text names, not a CPE, and are matched less certainly. This product uses the NVD API but is not endorsed or certified by the NVD.